Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

frosst iberica s.a. - natrijev bemiparinat - raztopina za injiciranje v napolnjeni injekcijski brizgi - natrijev bemiparinat 10000 i.e. / 0,2 ml - bemiparin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

frosst iberica s.a. - natrijev bemiparinat - raztopina za injiciranje v napolnjeni injekcijski brizgi - natrijev bemiparinat 10000 i.e. / 0,4 ml - bemiparin

Evropska unija - slovenščina - EMA (European Medicines Agency)

accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.

Evropska unija - slovenščina - EMA (European Medicines Agency)

viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - oftalmologi - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - fentanil - transdermalni obliž - fentanil 34,65 mg / 1 obliž - fentanil

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - fentanil - transdermalni obliž - fentanil 11,56 mg / 1 obliž - fentanil

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - fentanil - transdermalni obliž - fentanil 2,89 mg / 1 obliž - fentanil

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - fentanil - transdermalni obliž - fentanil 5,78 mg / 1 obliž - fentanil

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - fentanil - transdermalni obliž - fentanil 23,12 mg / 1 obliž - fentanil

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

shire pharmaceuticals ireland limited - lantan - žvečljiva tableta - lantan 750 mg / 1 tableta - lantanov(iii) karbonat